Dare Bioscience (DARE) Accumulated Expenses (2013 - 2026)

Dare Bioscience (DARE) has 13 years of Accumulated Expenses data on file, last reported at $725184.0 in Q4 2025.

• Quarterly Accumulated Expenses fell 76.17% year-over-year to $725184.0 in Q4 2025, while the trailing twelve-month figure through Dec 2025 was $725184.0 (down 76.17% YoY) and the FY2025 annual result came in at $725184.0, down 76.17% from the prior year.
• Accumulated Expenses slipped to $725184.0 in Q4 2025, from $2.3 million in the prior quarter.
• In the past five years, Accumulated Expenses ranged from a high of $10.9 million in Q4 2022 to a low of $250000.0 in Q2 2021.
• A 5-year average of $3.4 million and a median of $3.0 million in 2023 frame the typical range for Accumulated Expenses.
• Annual changes were most pronounced in 2021 — Accumulated Expenses plunged 84.76% — and 2022, when it surged 2438.95%.
• Tracing DARE's Accumulated Expenses over 5 years: stood at $3.1 million in 2021, then jumped by 247.36% to $10.9 million in 2022, then slumped by 73.48% to $2.9 million in 2023, then increased by 5.33% to $3.0 million in 2024, then tumbled by 76.17% to $725184.0 in 2025.
• The last three Accumulated Expenses figures came in at $725184.0 (Q4 2025), $2.3 million (Q3 2025), and $2.5 million (Q2 2025), per Business Quant data.